Managing the Diabetic Foot

Managing the Diabetic Foot

by Michael E Edmonds, Alethea VM Foster
     
 

View All Available Formats & Editions

Written by the BMA award-winning author team of Mike Edmonds and Alethea Foster

Aimed at podiatrists, nurses, physicians, surgeons, orthotists and all other members of the multidisciplinary diabetic foot team, Managing the Diabetic Foot, Second Edition, remains a “must-have” for all those interested in diabetes and the diabetic foot.

Overview

Written by the BMA award-winning author team of Mike Edmonds and Alethea Foster

Aimed at podiatrists, nurses, physicians, surgeons, orthotists and all other members of the multidisciplinary diabetic foot team, Managing the Diabetic Foot, Second Edition, remains a “must-have” for all those interested in diabetes and the diabetic foot.


New features of this Second Edition include:

  • Chapter on amputation has been expanded as has the overall surgical focus
  • Metabolic control and all other aspects of management have also been extensively updated
  • New introductory chapter which describes the assessment of the diabetic foot, incorporating an illustrated section on differential diagnosis
  • Content aids the implementation of the NICE guidelines and the ‘National Service Framework for Diabetes’

Editorial Reviews

Reviewer: Martin C. Yorath, DPM(Rosalind Franklin University of Medicine and Science)
Description: This pocket-sized book provides a succinct overview of the challenging and complex area of clinical management of the diabetic foot. The first edition was published in 2000.
Purpose: The purpose is to reinforce the multidisciplinary approach that is necessary with diabetic patients, and while there are several on this subject, there are few, if any which provide this type of breadth in such a small volume. The concept of early diagnosis and treatment is reinforced throughout.
Audience: Aimed at all involved in the management of the diabetic foot, both medical and nonmedical, the book sends its message to the target audiences well. Michael Edmonds and Ali Foster are a British Medical Association co-author award winning team, and are well respected within this field.
Features: The book is arranged into six sections, covering all of the clinical conditions from the "normal" diabetic foot through to the unsalvageable foot. Each section is color coded for easy reference, with an appendix covering differential diagnosis for the foot in diabetes. Overall, it is a very easy book to use and read. Color photography is extensively used throughout, and imaging studies are well reproduced. Tables are frequently used as well. References are not cited, but there is a short further reading list at the end of the book.
Assessment: This is an excellent book, and while there are more extensive books available, few are able to put it together as neatly and simply as this one does. The second edition is justified for its enhanced coverage of the neuropathic foot, metabolic management, amputee management, and some aspects of surgical management. While clearly aimed at the U.K. market, the general principles discussed here are just as valid in the United States. It is highly recommended.

Product Details

ISBN-13:
9780632055838
Publisher:
Wiley
Publication date:
04/17/2000
Edition description:
Older Edition
Pages:
134
Product dimensions:
4.76(w) x 7.52(h) x 0.28(d)

Related Subjects

Meet the Author

Michael E Edmonds MD FRCP, Consultant Physician, Diabetic Foot Clinic, King’s Diabetes Centre, King’s College Hospital, London, UK. Dr Edmonds is a world-renowned expert on foot problems in diabetes. He has lectured on the topic throughout the world and gave the inaugural Roger Pecoraro Lecture at the American Diabetes Association's annual meeting. He is also Chairman of the Diabetic Foot Study Group of the European Association for the Study of Diabetes.

Alethea V M Foster BA(Hons) PGCE MChS SRCh DipPodM, Chief Podiatrist, Diabetic Foot Clinic, King’s Diabetes Centre, King’s College Hospital, London, UK. Alethea was involved in the development of the UK Government's National Service Framework for Diabetes which are being implement in all hospitals, clinics and primary care practices by April 2004. In May 2003, Alethea was the first podiatrist to be awarded the International Diabetic Foot Award, which is only awarded every four years to an individual who has played a pivotal role in developing diabetic foot care.

Two per cent of the world's population have diabetes and of these, ten per cent will have a foot ulcer at any one time. Foot ulcers in diabetics are difficult to treat and very slow to heal. They result in more amputations than any other pathology. Severe ulcers are very debilitating, often require hospitalisation (half of all diabetic patients in hospital have foot ulcers) and can even result in death through complications such as gangrene and septicaemia.

Foot problems in diabetic patients are very difficult to treat. Therefore visual recognition of presenting clinical signs is a vital component of early diagnosis and start of treatment. Treatment in this field is developing with the launch of 'synthetic' skin grafts such as Apligraf (Novartis).

In the UK, the Department of Health published guidelines for the National Service Framework for Diabetes in December 2001. Alethea Foster was involved in the development of these guidelines. They are to be implemented in all hospitals/clinics/GP practices by April 2004 and call for 'proficient, rapid foot care for patients'. This book will reflect the changes resulting from the implementation of these guidelines.

Although these guidelines are only those adopted in the UK, the book will have a global focus. The information presented will be relevant to anyone involved in treating diabetic patients.

The previous approach to the first edition, incorporating numerous practical tips on the day to day assessment and management of the diabetic foot (which are not covered in any other diabetic foot books) will be expanded and made more formal by including an appropriate section in each chapter on practical management hints.

There will be a new introductory chapter describing the assessment of the diabetic foot incorporating an illustrated section on differential diagnosis. However, the basic framework of the book will be similar to the first edition as follows: infected foot, necrotic foot and unsalvageable foot. However, each section will undergo substantial revision as described below:

Low-risk foot: new approaches to blood glucose control, lipids and blood pressure management, as demonstrated by recent landmark trials, will be incorporated. The use of statins, ACE inhibitors and anti-platelet agents all have new indications.

High-risk foot: section on neuropathy will be expanded to include new approaches to neuropathy management (PKC inhibitor, Eli Lily drug) and management of painful neuropathy (gabapentin, Pfeizer).

Ulcerated foot: notes on differential diagnosis will be added including squamous cell carcinomas and gouty ulcers which we have recently added to our collection: new approaches to management of ulceration including the VAC pump, Kerraboot (Ark therapeutics’ new product), the pulse compression boot, silver dressings, promogran, MPIs (metallo-protease inhibitors), maggots, and wound odour management with new therapies, will all be incorporated. New techniques of off-loading such as the PRAFO (Pressure-relieving ankle foot orthosis) and the knee scooter will be included, as will the time-honoured podiatric technique of adhesive felt padding. More practical details on manufacture and use of the Scotchcast boot for ischaemic ulceration will be covered.

Infected foot: an expanded section on infection will include detailed consideration of MRSA and new resistant gram negative microorganisms. The very early signs of infection will be elaborated upon and osteomyelitis will be revisited. The use of MRI in the assessment of the infected foot to detect collections of pus and osteomyelitis will be discussed. New therapies including Linezolid (Pfizer drug) will be discussed.

The necrotic foot: the vascular assessment and management will be updated including MRI and new angioplasty techniques such as sub-intimal angioplasty and outpatient day case angioplasty. Protection from contrast nephropathy will be discussed, highlighting acetyl cysteine and the withdrawal of dopamine therapy (no longer used, but discussed in the previous edition). New techniques of blood vessel closure following angioplasty, such as the perclose technique will be discussed. Implications of end stage renal failure will be covered in more detail.

The unsalvageable foot section will be greatly extended to cover details of rehabilitation and prostheses.

Throughout all the sections the educational element will be expanded.

A new section on Charcot’s osteoarthropathy will be written to incorporate new approaches to diagnosis and management, including the CROW walker and reconstructive surgery.

A new section will cover diabetic foot surgery.

Customer Reviews

Average Review:

Write a Review

and post it to your social network

     

Most Helpful Customer Reviews

See all customer reviews >